Open access
Implementing pharmacogenomics for LAI antipsychotics
Abstract
Differences among individuals in drug exposure and response are well‐known variables for practicing clinicians. Over the last few decades, investigators have begun to present evidence for how pharmacogenetic strategies might optimize treatment for patients based on their genetic determinants of drug efficacy and toxicity.